Yingli Ma insider trades
Open-market stock purchases and sales by Yingli Ma, CHIEF TECHNOLOGY OFFICER at Structure Therapeutics Inc, from SEC Form 4 filings since Mar 15, 2024.
Companies traded
- GPCR Structure Therapeutics Inc: other filings, last Mar 19, 2026